The store will not work correctly when cookies are disabled.
1-Ethenyl-6,8-difluoro-7-(4-hydroxymethyl-piperidinyl)-4(1H)-oxoquinoline-3-carboxylic acid
ID: ALA1631376
PubChem CID: 50907732
Max Phase: Preclinical
Molecular Formula: C18H20F2N2O4
Molecular Weight: 366.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCC(CO)CC3)c(F)c21
Standard InChI: InChI=1S/C18H20F2N2O4/c1-2-21-8-12(18(25)26)17(24)11-7-13(19)16(14(20)15(11)21)22-5-3-10(9-23)4-6-22/h7-8,10,23H,2-6,9H2,1H3,(H,25,26)
Standard InChI Key: QNGDHYLAXURQET-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
17.0652 -18.2041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0641 -19.0315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7789 -19.4444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7771 -17.7914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4925 -18.2005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4932 -19.0273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2085 -19.4383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9236 -19.0235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9188 -18.1936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2029 -17.7863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3507 -17.7918 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.3493 -19.4434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7808 -20.2694 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.1985 -16.9614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6307 -17.7767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3477 -18.1849 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6257 -16.9517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2103 -20.2633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9256 -20.6743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6389 -19.0259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9262 -19.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9213 -20.2596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6353 -20.6749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3542 -20.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2049 -20.6689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4924 -20.2531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
3 13 1 0
3 6 2 0
10 14 2 0
6 7 1 0
9 15 1 0
1 2 2 0
15 16 1 0
7 8 1 0
15 17 2 0
5 4 2 0
7 18 1 0
8 9 2 0
18 19 1 0
12 20 1 0
4 1 1 0
9 10 1 0
10 5 1 0
1 11 1 0
12 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
2 3 1 0
22 25 1 0
2 12 1 0
25 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.36 | Molecular Weight (Monoisotopic): 366.1391 | AlogP: 2.21 | #Rotatable Bonds: 4 |
Polar Surface Area: 82.77 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.76 | CX Basic pKa: ┄ | CX LogP: 1.90 | CX LogD: 0.25 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.87 | Np Likeness Score: -0.59 |
References
1. Srinivasan S, Beema Shafreen RM, Nithyanand P, Manisankar P, Pandian SK.. (2010) Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives., 45 (12): [PMID:20933306] [10.1016/j.ejmech.2010.09.036] |